Clinical Trial Update: A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating trilaciclib in combination with chemotherapy for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• trilaciclib (trilaciclib)

Snippet

Sponsor: Taixing People's Hospital | Conditions: NSCLC | Phase 2 | Status: UNKNOWN